Free Trial
OTCMKTS:CVALF

Covalon Technologies (CVALF) Stock Price, News & Analysis

Covalon Technologies logo
$2.78 -0.10 (-3.34%)
As of 03:54 PM Eastern

About Covalon Technologies Stock (OTCMKTS:CVALF)

Advanced

Key Stats

Today's Range
$2.78
▼
$2.88
50-Day Range
$1.58
▼
$3.20
52-Week Range
$1.16
▼
$3.65
Volume
22,481 shs
Average Volume
12,814 shs
Market Capitalization
$76.78 million
P/E Ratio
25.28
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covalon Technologies Ltd. is a Canadian medical technology company that develops, manufactures and commercializes products designed to improve patient outcomes and reduce complications associated with wound care and medical procedures. Its technologies are intended for use by hospitals, healthcare professionals and patients in a range of clinical settings.

The company’s product portfolio includes advanced wound-care products, collagen-based dressings and antimicrobial solutions. Its offerings have included the ColActive line of wound dressings, including products formulated for different wound-management needs, as well as technologies intended to help protect skin and medical-device insertion sites from infection and damage. Covalon also develops medical coatings and other proprietary technologies for surgical and healthcare applications.

Covalon is headquartered in Canada and has pursued commercialization through healthcare markets in Canada, the United States and other international jurisdictions. The company’s business is focused on developing and bringing to market proprietary medical products through regulatory approvals, healthcare partnerships and sales to institutional and clinical customers.

AI Generated. May Contain Errors.

Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVALF Stock News Headlines

Covalon Technologies Ltd. (OTCMKTS:CVALF) Stock Short Interest Rises 108.7%
Covalon Reports Fiscal 2026 Third Quarter Results
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.tc pixel
Covalon Technologies Ltd CVALF
Covalon Reports 2026 Second Quarter Results
See More Headlines

CVALF Stock Analysis - Frequently Asked Questions

Covalon Technologies' stock was trading at $1.25 on January 1st, 2026. Since then, CVALF shares have increased by 123.2% and is now trading at $2.79.

Covalon Technologies Ltd. (OTCMKTS:CVALF) issued its earnings results on Thursday, August, 27th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.06. The company earned $7.07 million during the quarter, compared to the consensus estimate of $6.65 million. Covalon Technologies had a net margin of 12.77% and a trailing twelve-month return on equity of 15.11%.

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/27/2026
Today
10/14/2026
Next Earnings (Estimated)
12/10/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:CVALF
CIK
N/A
Fax
N/A
Employees
105
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.11
Trailing P/E Ratio
25.28
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.47 million
Net Margins
12.77%
Pretax Margin
12.79%
Return on Equity
15.11%
Return on Assets
12.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.56
Quick Ratio
6.62

Sales & Book Value

Annual Sales
$23.43 million
Price / Sales
3.28
Cash Flow
$0.08 per share
Price / Cash Flow
36.93
Book Value
$0.80 per share
Price / Book
3.48

Miscellaneous

Outstanding Shares
27,620,000
Free Float
N/A
Market Cap
$76.78 million
Optionable
Not Optionable
Beta
0.78
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:CVALF) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners